Cochrane Evidence Synthesis and Methods ►

Prognostic value of blood eosinophils for predicting survival and treatment outcomes in people with non-small cell lung cancer

This is a protocol for a Cochrane Review (prognosis). The objectives are as follows:

To assess the prognostic value of measuring pretreatment baseline blood eosinophil levels in adults receiving systemic treatment for any stage of non-small cell lung cancer.

This is a protocol.

Published:

7 February 2025

Authors:

Sultana H, De Vos T, Malouf R, Calais F, Marchal C, Eberst G, Westeel V, Barnig C

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Sultana H, De Vos T, Malouf R, Calais F, Marchal C, Eberst G, Westeel V, Barnig C. Prognostic value of blood eosinophils for predicting survival and treatment outcomes in people with non-small cell lung cancer (Protocol). Cochrane Database of Systematic Reviews 2025, Issue 2. Art. No.: CD015783. DOI: 10.1002/14651858.CD015783.